STOCK TITAN

IMVT (NASDAQ: IMVT) files Form 144 reporting 6,000-share option exercise sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Issuer files a Form 144 reporting proposed sale and recent dispositions of Common Stock. The filing lists 6,000 shares tied to an exercise of stock options with a proposed sale date of 06/15/2026. It also reports prior 10b5-1 sales of 6,000 shares on 05/20/2026 for $192,000.

Positive

  • None.

Negative

  • None.

Insights

Routine resale notice and exercise disclosure under Rule 144 with a prior 10b5-1 sale.

The filing records a planned sale of 6,000 shares associated with an exercise of stock options and cites a prior 10b5-1 sale of 6,000 shares on 05/20/2026 for $192,000. This is a regulatory notice of intent to sell and an exercise-related transaction.

Timing and cash‑flow treatment are stated as cash and dated 06/15/2026. Future filings (if any) would show actual settlement and change in beneficial ownership; the current record is a standard disclosure under resale rules.

Proposed shares to sell 6,000 shares Exercise of stock options dated 06/15/2026
Prior sale quantity 6,000 shares 10b5-1 sales on 05/20/2026
Proceeds from prior sale $192,000 10b5-1 sale on 05/20/2026
Planned sale date 06/15/2026 Date listed for exercise/sale
10b5-1 regulatory
"10b5-1 Sales for ATUL PANDE 1000 Park Forty Plaza"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Exercise of Stock Options financial
"Securities To Be Sold | Exercise of Stock Options | Issuer"
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does IMVT's Form 144 report?

It reports a proposed sale of 6,000 shares tied to an exercise of stock options dated 06/15/2026. The filing also discloses prior 10b5-1 sales of 6,000 shares on 05/20/2026 for $192,000.

Who executed the prior 10b5-1 sales noted in the filing?

The filing identifies 10b5-1 sales for Atul Pande on 05/20/2026 totaling 6,000 shares and producing $192,000. The entry is a reported disposition under an established trading plan.

Are the 6,000 shares being sold part of an option exercise?

Yes. The Form 144 lists 6,000 shares under "Exercise of Stock Options" with a proposed sale method and a sale date of 06/15/2026, and indicates cash as the consideration method.

Does the filing state how much cash the issuer or seller will receive?

The filing shows prior 10b5-1 sales produced $192,000 for 6,000 shares. For the proposed 06/15/2026 exercise-and-sale, the filing lists cash as the method but does not state a dollar amount for that planned sale.